CYTK biotech catalysts & pipeline

CYTOKINETICS INC · Data as of 2026-10-25

Upcoming catalysts

MYQORZO (aficamten) — NDA/BLA submission

this quarter

We plan to submit a supplemental New Drug Application to the FDA this quarter.

MYQORZO (aficamten) — PDUFA

Nov 14

The Supplemental New Drug Application for MAPLE-HCM was accepted for filing by the U.S. Food and Drug Administration (FDA) with a PDUFA date of November 14, 2026.

Source filing

Explore the free biotech catalyst calendar